Literature DB >> 48833

Plasma exchange in the management of homozygous familial hypercholesterolaemia.

G R Thompson, R Lowenthal, N B Myant.   

Abstract

Two young women with homozygous familial hypercholesterolaemia and coronary and aortic atheroma were treated by repeated plasma exchange, using a continuous-flow blood-cell separator, for 4 and 8 months. A pronounced reduction in plasma cholesterol and low-density lipoprotein (L.D.L.) concentrations was achieved by exchanging each patient's plasma with cholesterol-free plasma protein fraction (B.P.), at 3-weekly intervals on an outpatient basis. By pre-labelling the patients' cholesterol with 14-C and comparing the specific activity of the cholesterol in adipose tissue with that in plasma, evidence was obtained of an influx of tissue cholesterol into plasma after each exchange. There was no side-effects and both patients lost their angina. Plasma exchange offers a new and practical approach to the long-term management of this lethal disorder and may also provide information about the possible reversibility of human atheroma.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 48833     DOI: 10.1016/s0140-6736(75)92193-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  40 in total

Review 1.  Incorporation of low-density lipoprotein apheresis into the treatment program of patients with severe hypercholesterolemia.

Authors:  B R Gordon
Journal:  Curr Atheroscler Rep       Date:  2000-07       Impact factor: 5.113

Review 2.  [Plaque stabilization by LDL apheresis?].

Authors:  P Schuff-Werner; V Schettler
Journal:  Herz       Date:  1999-02       Impact factor: 1.443

3.  Plasma exchange and plasmapheresis.

Authors:  N A Buskard
Journal:  Can Med Assoc J       Date:  1978-10-07       Impact factor: 8.262

Review 4.  Lipoprotein apheresis to treat elevated lipoprotein (a).

Authors:  Elisa Waldmann; Klaus G Parhofer
Journal:  J Lipid Res       Date:  2016-02-17       Impact factor: 5.922

5.  LDL-apheresis therapy.

Authors:  Patrick M Moriarty
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-08

Review 6.  Lipoprotein apheresis.

Authors:  Vijay G Bhoj; Bruce S Sachais
Journal:  Curr Atheroscler Rep       Date:  2015-07       Impact factor: 5.113

7.  Lipoprotein-apheresis: Austrian consensus on indication and performance of treatment.

Authors:  Kurt Derfler; Sabine Steiner; Helmut Sinzinger
Journal:  Wien Klin Wochenschr       Date:  2015-07-23       Impact factor: 1.704

8.  Degradation of lipoproteins by human monocyte-derived macrophages. Evidence for two distinct processes for the degradation of abnormal very-low-density lipoprotein from subjects with type III hyperlipidaemia.

Authors:  A K Soutar; B L Knight
Journal:  Biochem J       Date:  1984-02-15       Impact factor: 3.857

9.  [Drug treatment of primary hyperlipoproteinemia (author's transl)].

Authors:  G Klose; R Mordasini; G Middelhoff; J Augustin; H Greten
Journal:  Klin Wochenschr       Date:  1978-02-01

10.  Relationship between corneal arcus and hyperlipidaemia is clarified by studies in familial hypercholesterolaemia.

Authors:  A F Winder
Journal:  Br J Ophthalmol       Date:  1983-12       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.